Bio-key International, Inc. (NASDAQ: BKYI) reported Q2 EPS of ($0.21), $0.13 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $2.5 million.

For earnings history and earnings-related data on Bio-key International, Inc. (BKYI) click here.